PLA-based core-shell structure stereocomplexed nanoparticles with enhanced loading and release profile of paclitaxel
Author(s) -
Yuemin Wang,
Siyuan Cui,
Bing Wu,
Quanxing Zhang,
Wei Jiang
Publication year - 2021
Publication title -
frontiers in bioscience-landmark
Language(s) - English
Resource type - Journals
eISSN - 2768-6701
pISSN - 2768-6698
DOI - 10.52586/4964
Subject(s) - micelle , polylactic acid , copolymer , nanocarriers , paclitaxel , nanoparticle , polyethylene glycol , polymer chemistry , conjugated system , drug delivery , particle size , chemical engineering , chemistry , materials science , nanotechnology , organic chemistry , polymer , aqueous solution , medicine , surgery , chemotherapy , engineering
Purpose : In the present study, to achieve high paclitaxel (PTX) loading in a conjugated drug delivery system with minimal long-term side effects, we formulated a novel degradable stereocomplexed micelle-like particle with a core-shell structure. Materials and methods : In this system, methoxy polyethylene glycol (MPEG) acted as the hydrophilic shell, and the stereocomplex of polylactic acid with PTX (SCPLA-PTX) acted as the hydrophobic core. The MPEG-SCPLA-PTX micelle-like particles were synthesized via the self-assembly of a MPEG-poly L-lactic acid (PLLA) copolymer with a PTX-poly D-lactic acid-PTX copolymer. The resultant copolymers and their intermediates were characterized using 1 H nuclear magnetic resonance and GPC. Micelle-like particles with different molecular weight ratios of MPEG and PLLA were synthesized to demonstrate the functions of both components. Results : PTX loading into MPEG2000Da-PLLA6000Da particles reached as high as 20.11%. At 216 h, the cumulative release from MPEG5000Da-PLLA6000Da, MPEG2000Da-PLLA6000Da, and MPEG5000Da-PLLA22000Da particles were 51.5%, 37.7%, and 52.0%, respectively. Conclusions : According to the cell uptake experiments, inhibition of tumor cell growth was satisfactory, indicating that the stereocomplexed particles developed in the present study can be employed as a promising nanocarrier for PTX delivery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom